Sagimet to Present Phase 2 Data on Lead Candidate TVB-2640 at The International Liver Congressâ„¢ 2021 (EASL)
San Mateo, California, April 23, 2021 – Sagimet Biosciences, a clinical-stage biotechnology company focused on developing a portfolio of internally-discovered, selective […]